# Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins

> **NCT03557671** · NA · COMPLETED · sponsor: **United Pharmaceuticals** · enrollment: 72 (actual)

## Conditions studied

- Cow Milk Allergy

## Interventions

- **DIETARY_SUPPLEMENT:** rice formula
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT03557671
- **Lead sponsor:** United Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-23
- **Primary completion:** 2020-09-21
- **Final completion:** 2020-09-21
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2020-11-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03557671

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03557671, "Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03557671. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
